1. Home
  2. ALDX vs BNED Comparison

ALDX vs BNED Comparison

Compare ALDX & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • BNED
  • Stock Information
  • Founded
  • ALDX 2004
  • BNED 1965
  • Country
  • ALDX United States
  • BNED United States
  • Employees
  • ALDX N/A
  • BNED N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • BNED Other Specialty Stores
  • Sector
  • ALDX Health Care
  • BNED Consumer Discretionary
  • Exchange
  • ALDX Nasdaq
  • BNED Nasdaq
  • Market Cap
  • ALDX 304.9M
  • BNED 335.1M
  • IPO Year
  • ALDX 2014
  • BNED N/A
  • Fundamental
  • Price
  • ALDX $6.76
  • BNED $10.49
  • Analyst Decision
  • ALDX Strong Buy
  • BNED Hold
  • Analyst Count
  • ALDX 2
  • BNED 1
  • Target Price
  • ALDX $10.00
  • BNED N/A
  • AVG Volume (30 Days)
  • ALDX 698.6K
  • BNED 424.4K
  • Earning Date
  • ALDX 05-01-2025
  • BNED 03-10-2025
  • Dividend Yield
  • ALDX N/A
  • BNED N/A
  • EPS Growth
  • ALDX N/A
  • BNED N/A
  • EPS
  • ALDX N/A
  • BNED N/A
  • Revenue
  • ALDX N/A
  • BNED $1,567,800,000.00
  • Revenue This Year
  • ALDX N/A
  • BNED $2.74
  • Revenue Next Year
  • ALDX N/A
  • BNED N/A
  • P/E Ratio
  • ALDX N/A
  • BNED N/A
  • Revenue Growth
  • ALDX N/A
  • BNED N/A
  • 52 Week Low
  • ALDX $2.85
  • BNED $6.05
  • 52 Week High
  • ALDX $7.20
  • BNED $135.00
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 54.11
  • BNED 59.14
  • Support Level
  • ALDX $6.22
  • BNED $9.55
  • Resistance Level
  • ALDX $6.87
  • BNED $10.75
  • Average True Range (ATR)
  • ALDX 0.44
  • BNED 0.63
  • MACD
  • ALDX -0.03
  • BNED 0.21
  • Stochastic Oscillator
  • ALDX 56.30
  • BNED 93.63

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: